- Home
- COLB vs MIRM Comparison
COLB vs MIRM Comparison
Compare COLB & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLB | MIRM |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2B | 7.4B |
| IPO Year | 1996 | 2019 |
Fundamental Metrics
Financial Performance| Metric | COLB | MIRM |
|---|---|---|
| Price | $32.02 | $119.90 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $31.46 | ★ $119.85 |
| AVG Volume (30 Days) | ★ 2.8M | 967.0K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.08% | N/A |
| EPS Growth | N/A | ★ 74.59 |
| EPS | ★ 0.66 | N/A |
| Revenue | ★ $177,000,000.00 | $19,138,000.00 |
| Revenue This Year | $31.52 | $26.22 |
| Revenue Next Year | $2.90 | $22.04 |
| P/E Ratio | $48.55 | ★ N/A |
| Revenue Growth | ★ 18.94 | N/A |
| 52 Week Low | $22.78 | $50.25 |
| 52 Week High | $32.77 | $130.00 |
Technical Indicators
Market Signals| Indicator | COLB | MIRM |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 57.27 |
| Support Level | $28.61 | $88.92 |
| Resistance Level | $32.74 | N/A |
| Average True Range (ATR) | 0.65 | 6.48 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 62.68 | 59.29 |
Price Performance
Historical ComparisonAbout COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
About MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.